Daniel Carpio - Concepedia

Author

Daniel Carpio

Complejo Hospitalario de Pontevedra ORCID

Also Known As

A. Carmona, Belén Botella, Carpio, Carpio D, D CARPIO, D Carpio, D Carpio López, D. Carpio, D. Lopez, Daniel Carpio

180

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Complejo Hospitalario de Pontevedra Hospital Universitario de La Princesa Austral University of Chile Universidad Autónoma de Madrid Complejo Hospitalario Universitario de Santiago

About

Daniel Carpio is an author at Complejo Hospitalario de Pontevedra specializing in medicine, chronic kidney disease, and nephrology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	498
2	Public Health	3	3	79
3	Health Sciences	1	1	29
4	Natural Sciences	1	1	130
5	Biomedical Engineering	1	1	65

Daniel Carpio

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Systemic Administration of Multipotent Mesenchymal Stromal Cells Reverts Hyperglycemia and Prevents Nephropathy in Type 1 Diabetic Mice Fernando Ezquer, Marcelo Ezquer, Daniela B. Parrau, Biology of Blood and Marrow Transplantation	2008	351
Lyso-Gb3 activates Notch1 in human podocytes María Dolores Sánchez-Niño, Daniel Carpio, Ana B. Sanz, Human Molecular Genetics Molecular RegulationImmunologyInnate ImmunityCellular PhysiologyNotch1 Signaling	2015	130
Human adipose-derived mesenchymal stem cell-conditioned medium ameliorates polyneuropathy and foot ulceration in diabetic BKS db/db mice Cristian De Gregorio, David Contador, Diego A. Díaz, Stem Cell Research & Therapy	2020	104
Efficacy of infliximab rescue therapy in patients with chronic refractory pouchitis: A multicenter study B Acosta, Orlando García‐Bosch, R. Souto, Inflammatory Bowel Diseases	2011	103
Endovenous Administration of Bone Marrow-Derived Multipotent Mesenchymal Stromal Cells Prevents Renal Failure in Diabetic Mice Fernando Ezquer, Marcelo Ezquer, Valeska Simon, Biology of Blood and Marrow Transplantation	2009	99
Thiopurine methyl-transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine-treated inflammatory bowel disease patients Yago González‐Lama, Fernando Bermejo, Antonio López–Sanromán, Alimentary Pharmacology & Therapeutics	2011	86
Seven‐day ‘rescue’ therapy after <i>Helicobacter pylori</i> treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole Gisbert, Gisbert, Marcos Marcos, Alimentary Pharmacology & Therapeutics	1999	82
Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry María Chaparro, A Garre, Marisa Iborra, Journal of Crohn s and Colitis	2021	79
Real‐world short‐term effectiveness of ustekinumab in 305 patients with Crohn’s disease: results from the ENEIDA registry Marisa Iborra, Belén Beltrán, A Fernández-Clotet, Alimentary Pharmacology & Therapeutics	2019	70
Effectiveness of Adalimumab in Perianal Fistulas in Crohn’s Disease Patients Naive to Anti-TNF Therapy Carlos Castaño-Milla, María Chaparro, Cristina Saro, Journal of Clinical Gastroenterology	2014	69

Page 1